CN1486178A - 组胺受体拮抗剂 - Google Patents

组胺受体拮抗剂 Download PDF

Info

Publication number
CN1486178A
CN1486178A CNA028036840A CN02803684A CN1486178A CN 1486178 A CN1486178 A CN 1486178A CN A028036840 A CNA028036840 A CN A028036840A CN 02803684 A CN02803684 A CN 02803684A CN 1486178 A CN1486178 A CN 1486178A
Authority
CN
China
Prior art keywords
histamine
receptor
antagonist
receptors
selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028036840A
Other languages
English (en)
Chinese (zh)
Inventor
˹�ٷҡ�ղ��ɭ
斯蒂芬·詹金森
A
马克·A·奥赖利
A����ά
迈克尔·A·特里维西克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CN1486178A publication Critical patent/CN1486178A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA028036840A 2001-01-17 2002-01-10 组胺受体拮抗剂 Pending CN1486178A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0101223.6 2001-01-17
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
CN1486178A true CN1486178A (zh) 2004-03-31

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028036840A Pending CN1486178A (zh) 2001-01-17 2002-01-10 组胺受体拮抗剂

Country Status (32)

Country Link
EP (1) EP1353657A1 (is)
JP (1) JP2004517883A (is)
KR (1) KR20030069216A (is)
CN (1) CN1486178A (is)
AP (1) AP2002002401A0 (is)
AR (1) AR032101A1 (is)
BG (1) BG107834A (is)
BR (1) BR0206502A (is)
CA (1) CA2435121A1 (is)
CR (1) CR6983A (is)
CZ (1) CZ20031853A3 (is)
DO (1) DOP2002000325A (is)
EA (1) EA200300537A1 (is)
EC (1) ECSP034692A (is)
EE (1) EE200300335A (is)
GB (1) GB0101223D0 (is)
GT (1) GT200200003A (is)
HU (1) HUP0302767A2 (is)
IL (1) IL156087A0 (is)
IS (1) IS6818A (is)
MA (1) MA26980A1 (is)
MX (1) MXPA03006408A (is)
NO (1) NO20033223L (is)
OA (1) OA12440A (is)
PA (1) PA8537101A1 (is)
PL (1) PL362793A1 (is)
PY (1) PY0200477A (is)
SK (1) SK8572003A3 (is)
SV (1) SV2003000849A (is)
TN (1) TNSN02003A1 (is)
WO (1) WO2002056871A2 (is)
ZA (1) ZA200304180B (is)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119823227A (zh) * 2025-01-14 2025-04-15 北京川晋生物科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
MXPA05002577A (es) * 2002-09-06 2005-09-20 Johnson & Johnson Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma.
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3378476A1 (en) 2012-06-08 2018-09-26 Sensorion H4 receptor inhibitors for treating tinnitus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119823227A (zh) * 2025-01-14 2025-04-15 北京川晋生物科技有限公司 一种益生菌的制备方法及其在治疗过敏性鼻炎中的用途

Also Published As

Publication number Publication date
DOP2002000325A (es) 2003-01-31
NO20033223D0 (no) 2003-07-16
EE200300335A (et) 2003-12-15
MA26980A1 (fr) 2004-12-20
PL362793A1 (pl) 2004-11-02
IL156087A0 (en) 2003-12-23
GT200200003A (es) 2002-08-19
CZ20031853A3 (cs) 2004-07-14
JP2004517883A (ja) 2004-06-17
AR032101A1 (es) 2003-10-22
BR0206502A (pt) 2003-10-21
HUP0302767A2 (hu) 2003-11-28
CR6983A (es) 2003-11-25
TNSN02003A1 (fr) 2005-12-23
AP2002002401A0 (en) 2002-03-31
SK8572003A3 (en) 2004-07-07
MXPA03006408A (es) 2003-10-15
SV2003000849A (es) 2003-01-13
KR20030069216A (ko) 2003-08-25
EA200300537A1 (ru) 2004-02-26
GB0101223D0 (en) 2001-02-28
ZA200304180B (en) 2004-06-15
EP1353657A1 (en) 2003-10-22
IS6818A (is) 2003-05-15
CA2435121A1 (en) 2002-07-25
PY0200477A (es) 2004-06-01
ECSP034692A (es) 2003-08-29
BG107834A (bg) 2004-01-30
WO2002056871A2 (en) 2002-07-25
PA8537101A1 (es) 2002-08-29
NO20033223L (no) 2003-07-16
OA12440A (en) 2006-05-22

Similar Documents

Publication Publication Date Title
CN1784221B (zh) 影响体重减轻的组合物
US20020052312A1 (en) Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
AU2008259864B2 (en) Methods and compositions for administration of Oxybutynin
JP7433331B2 (ja) 特発性肺線維症を治療するための組成物及び方法
CN1486178A (zh) 组胺受体拮抗剂
US6780866B2 (en) Analgesic composition and method
US20240285612A1 (en) Compositions comprising an agonist of 5-hydroxytryptamine (5-ht) receptor subtype 3
AU2008333220B2 (en) Mequitazine for treating or preventing pathologies involving histamine H4 receptors
US20040138234A1 (en) Histamine receptor antagonists
HK1060300A (en) Histamine receptor antagonists
CN110325214A (zh) 用于预防和治疗神经元损伤的低剂量药物组合
AU2002216328A1 (en) Histamine receptor antagonists
JP6388791B2 (ja) Vpac1受容体活性化剤及びドライマウスの予防薬又は治療薬

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1060300

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1060300

Country of ref document: HK